• Fluorescein TSA Fluorescence System Kit Workflow

  2026-09-29

  Turn weak protein and nucleic-acid signals into spatially resolved fluorescence in fixed cells and tissues. This guide pairs the Fluorescein TSA Fluorescence System Kit with practical IHC, ICC, and ISH workflows, using the miR-3180–SCD1–CD36 HCC study as a model for assay planning and validation.

• Polyethylenimine Linear: PEI MW 40,000 Workflow

  2026-09-29

  Build a reproducible PEI transfection workflow for mechanistic cell studies, from HEK-293 reporter assays to chondrocyte models of osteoarthritis. This guide connects practical DNA delivery with the Piezo1–HBB metabolic axis while clearly separating validated in vitro use from exploratory nanoparticle translation.

• SW033291: From PGE2 Control to Tissue Repair

  2026-09-28

  SW033291 is a 15-PGDH inhibitor for dissecting how prostaglandin E2 elevation influences hematopoiesis and tissue repair. This article presents an evidence-chain framework that connects enzyme potency with cellular, regenerative, and functional readouts.

• Late-Stage Mechanics of Clathrin-Mediated Endocytosis

  2026-09-28

  Using multidimensional single-particle tracking, Wu and colleagues map rotational motions of clathrin-coated pits during late-stage endocytosis in living cells. Their findings distinguish a common dynamin-dependent in-plane twist from an actin-associated out-of-plane “swing,” suggesting that productive membrane remodeling can follow more than one mechanical route.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-27

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal cell populations, capturing features that are less evident in epithelial-only cultures. The model showed stromal-associated changes in gene expression and drug sensitivity, supporting its use for studying tumor–stroma interactions while underscoring that organoid drug responses may not predict assembloid responses.

• 1-Phenyl-2-Pentanol and Hepatic Stellate Cell Fibrosis

  2026-09-26

  A 2024 study examined 1-phenyl-2-pentanol, a compound identified from Moringa oleifera leaves, in TGF-β1-stimulated human hepatic stellate cells. The findings connect reduced fibrosis-associated markers with changes in Wnt/β-catenin signaling, while leaving the direct molecular target and in vivo relevance open for further study.

• CUDC-907: In Vitro Workflow and QC Guide

  2026-09-25

  CUDC-907 is a dual PI3K and HDAC inhibitor for in vitro studies that need to examine pathway signaling alongside histone acetylation, cell-cycle behavior, or apoptosis. This guide translates the product dossier into practical setup and QC steps; it is for scientific research only, not diagnostic, clinical, or therapeutic use.

• MK-571 (L-660,711): Evidence & Research Use

  2026-09-25

  MK-571, also called L-660,711, is a competitive cysteinyl leukotriene receptor 1 antagonist used in leukotriene-mediated inflammation research. Its reported receptor pharmacology and separate MRP1-inhibitory activity make target-specific controls essential when interpreting airway or transporter experiments.

• MK-8745: From Aurora A Biology to Assay Logic

  2026-09-24

  Explore how MK-8745, a potent Aurora A inhibitor, can help distinguish target expression from functional dependency in cancer models. A retinoblastoma study offers a practical framework for selecting models and interpreting cell-cycle, apoptosis, and tumor-response data.

• Niclosamide: From Target Claims to Assay Logic

  2026-09-24

  Niclosamide is a STAT3-pathway research compound, but interpreting its effects requires more than measuring a single endpoint. This article connects its reported cellular activity to a distinct lesson from a snail-control study: build experiments around dose, exposure time, orthogonal readouts, and explicit evidence boundaries.

• How Signaling Relates to Preputial Development

  2026-09-23

  A comparative study links later preputial development and open urethral-groove formation in guinea pigs with species differences in Shh and Fgf expression. Organ-culture perturbations add experimental context, while the findings remain limited to embryonic mouse and guinea-pig models.

• FAK Inhibitor 14: Applied Research Workflows

  2026-09-23

  FAK Inhibitor 14 provides a practical chemical approach for testing how focal adhesion kinase controls adhesion, migration, and EMT-associated phenotypes. This workflow-oriented guide connects compound handling with cholesterol-resistant ovarian cancer models, quantitative pathway assays, and troubleshooting strategies for reproducible cancer biology research.

• Cefepime in CREC Resistance Research

  2026-09-22

  Explore how Cefepime (BMY-28142) can function as a phenotypic probe in carbapenem-resistant Enterobacter cloacae research. This article connects antimicrobial susceptibility testing with plasmid localization, gene transfer, CNS-focused assay design, and neurotoxicity-aware interpretation.

• CTP-Guided mRNA Translation: From IVT to Bladder Cancer

  2026-09-22

  A translational perspective on how CTP quality and workflow control can support in vitro transcription for localized p21 mRNA–LNP therapy, while distinguishing upstream reagent performance from downstream delivery and therapeutic validation.

• Cy3 TSA Fluorescence System Kit for Spatial Imaging

  2026-09-21

  The Cy3 TSA Fluorescence System Kit converts weak antibody or probe recognition into a dense, microscopy-ready signal for difficult IHC, ICC, and ISH targets. This practical guide shows how to adapt TSA fluorescence amplification to spatial proteomics questions while controlling background, spectral overlap, and false localization.

556 records 3/38 page Previous Next 12345 下5页 Last page